EUVIMEDEUVIMED entdecken
Crossref

Phenylboronate hydrogel for administration route tailored dual-drug delivery to anterior and posterior ocular segments

Rui Xue Zhang, Xu Wang, Xu Yan, Wei Jia Yan, Xue-Ting Wang, Yan Chen, Xudong Deng, Weijia Lu, Yexuan Guo, Hong Yan

Journal of Controlled Release · 2026-11 · 399 · 115448

DOI: 10.1016/j.jconrel.2026.115448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-11. Verfasst von Rui Xue Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Precision Regenerative Medicine Research Centre, Macau University of Science and Technology, Macau, China; School of Pharmacy, and Faculty of Medicin…. Hauptthemen laut MEDLINE: Boronic Acids, Moxifloxacin, Hydrogels, Dexamethasone. Die Arbeit nennt 84 Literaturangaben. Gefördert von: High-end Foreign Experts Recruitment Plan of China, National Natural Science Foundation of China, Shaanxi Province Key Research and Development Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Frequent multidrug eyedrop instillation for ocular perioperative prophylaxis (e.g., cataract surgery) suffers from rapid nasolacrimal clearance, limited corneal penetration, and poor access to the posterior segment. To address these limitations, we engineered an interface-adaptive phenylboronate ester hydrogel for rapid in situ gelation and the co-entrapment of two frequently instilled drugs (moxifloxacin and dexamethasone) in their free or liposomal forms at physiological pH. This platform utilizes chemical crosslinking between hyaluronic acid-conjugated 2-aminophenylboronic acid and the diols of polyvinyl alcohol (HA-2APBA@PVA), forming a dynamic hydrogel network via phenylboronate ester bonds with a thermodynamically favorable formation energy (ΔG = -10.64 kcal/mol). This unique chemistry imparts shear-thinning injectability through fine ophthalmic needles, ensures mechanical stability against blink-induced shearing, and drives robust mucoadhesion with tear film mucins such as MUC5AC for prolonged ocular retention at the injection site. Architecturally, a "liposome-in-gel" system establishes hierarchical diffusion steps that suppress the initial burst effect and extend drug release duration by >2-fold compared to the free-drug solution control. The hydrogel demonstrates excellent ophthalmic compatibility, exhibiting physiological osmolality, >80% optical transmittance, and near 100% viability in human corneal and retinal pigment epithelial cells. Safety was further validated via Draize irritation testing and preserved ocular histology across topical and periocular administration routes. Unlike the rapid washout of standard eyedrops, this hydrogel depot ensures prolonged ocular surface retention. Pharmacokinetic analysis revealed route-dependent versatility: compared to standard eyedrops, subconjunctival administration enhanced anterior segment exposure of moxifloxacin and dexamethasone by 14.9- and 8.6-fold, respectively, while sub-Tenon dosing facilitated targeted delivery to the posterior segment. This single, dynamic covalent chemistry provides a scalable, clinically compatible alternative strategy to eyedrops and advances multidrug therapies across both ocular segments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boronic AcidsMoxifloxacinHydrogelsDexamethasoneDrug Delivery SystemsPosterior Eye SegmentAnimalsHumansPolyvinyl AlcoholAnterior Eye SegmentHyaluronic AcidLiposomesRabbits

Stichwörter der Autor:innen

Aminophenylboronic acidCornea-sclera barrierDynamic crosslinkingInjectable depotOcular pharmacokineticsPeriocular and topical administration

Substanzen

Boronic AcidsMoxifloxacinHydrogelsDexamethasonebenzeneboronic acidPolyvinyl AlcoholHyaluronic AcidLiposomes

Autor:innen und Institutionen

  • Precision Regenerative Medicine Research Centre, Macau University of Science and Technology, Macau, China; School of Pharmacy, and Faculty of Medicine, Macau University of Science and Technology, Macau, China; School of…
  • School of Life Science and Technology, Northwestern Polytechnical University, 127 West Youyi Road, Xi'an, China.
  • Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Weifang People's Hospital, Shandong Second Medical University, Weifang, China.
  • Precision Regenerative Medicine Research Centre, Macau University of Science and Technology, Macau, China; School of Pharmacy, and Faculty of Medicine, Macau University of Science and Technology, Macau, China.
  • School of Life Science and Technology, Northwestern Polytechnical University, 127 West Youyi Road, Xi'an, China; Shaanxi Eye Hospital, Xi'an People's Hospital (Xi'an Fourth Hospital), Affiliated People's Hospital of Nor…

Förderung

  • High-end Foreign Experts Recruitment Plan of China
  • National Natural Science Foundation of China
  • Shaanxi Province Key Research and Development Projects

Zitieren

APA

Zhang, R. X., Wang, X., Yan, X., Yan, W. J., Wang, X. T., Chen, Y., Deng, X., Lu, W., Guo, Y., & Yan, H. (2026). Phenylboronate hydrogel for administration route tailored dual-drug delivery to anterior and posterior ocular segments. Journal of Controlled Release, 399, 115448. https://doi.org/10.1016/j.jconrel.2026.115448

Vancouver

Zhang RX, Wang X, Yan X, Yan WJ, Wang XT, Chen Y, et al. Phenylboronate hydrogel for administration route tailored dual-drug delivery to anterior and posterior ocular segments. Journal of Controlled Release. 2026;399:115448. doi:10.1016/j.jconrel.2026.115448

BibTeX
@article{Zhang2026,
  author = {Zhang, Rui Xue and Wang, Xu and Yan, Xu and Yan, Wei Jia and Wang, Xue-Ting and Chen, Yan and Deng, Xudong and Lu, Weijia and Guo, Yexuan and Yan, Hong},
  title = {Phenylboronate hydrogel for administration route tailored dual-drug delivery to anterior and posterior ocular segments},
  journal = {Journal of Controlled Release},
  year = {2026},
  volume = {399},
  pages = {115448},
  doi = {10.1016/j.jconrel.2026.115448}
}
Kostenlos starten →